TTPAL promotes colorectal tumorigenesis by stabilizing TRIP6 to activate Wnt/β-catenin signaling

Hongyan Gou, Jessie Qiaoyi Liang, Lijing Zhang, Huarong Chen, Yanquan Zhang, Rui Li, Xiaohong Wang, Jiafu Ji, Joanna H. Tong, Ka Fai To, Joseph J.Y. Sung, Francis K.L. Chan, Jing Yuan Fang, Jun Yu

Research output: Contribution to journalArticlepeer-review

33 Scopus citations


Copy number alterations are crucial for the development of colorectal cancer. Our whole-genome analysis identified tocopherol alpha transfer protein-like (TTPAL) as preferentially amplified in colorectal cancer. Here we demonstrate that frequent copynumber gain of TTPAL leads to gene overexpression in colorectal cancer fromaChinese cohort (n=102),whichwas further validated by a The Cancer GenomeAtlas (TCGA) cohort (n = 376). High expression of TTPAL was significantly associated with shortened survival in patients with colorectal cancer. TTPAL promoted cell viability and clonogenicity, accelerated cell-cycle progression, inhibited cell apoptosis, increased cell migration/invasion ability in vitro, and promoted tumorigenicity and cancer metastasis in vivo. TTPAL significantly activated Wnt signaling and increased β-catenin activation and protein expression of cyclin D1 and c-Myc. Coimmunoprecipitation followed by mass spectrometry identified thyroid receptor- interacting protein 6 (TRIP6) as a direct downstreameffector of TTPAL. Depletion of TRIP6 significantly abolished the effects of TTPAL on cell proliferation and Wnt activation. Direct binding of TTPAL with TRIP6 in the cytoplasm inhibited ubiquitinmediated degradation of TRIP6 and, subsequently, increased levels of TRIP6 displaced β-catenin from the tumor suppressor MAGI1 via competitive binding. This sequence of events allows β-catenin to enter the nucleus and promotes oncogenic Wnt/ β-catenin signaling. In conclusion, TTPAL is commonly overexpressed in colorectal cancer due to copy number gain, which promotes colorectal tumorigenesis by activatingWnt/β-catenin signaling via stabilization of TRIP6. TTPAL overexpression may serve as an independent new biomarker for the prognosis of patients with colorectal cancer.

Original languageEnglish
Pages (from-to)3332-3346
Number of pages15
JournalCancer Research
Issue number13
StatePublished - 2019

Bibliographical note

Publisher Copyright:
© 2019 American Association for Cancer Research.

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'TTPAL promotes colorectal tumorigenesis by stabilizing TRIP6 to activate Wnt/β-catenin signaling'. Together they form a unique fingerprint.

Cite this